Your browser doesn't support javascript.
loading
Pain management recommendations during the progression of SARS-CoV-2 infection.
Dhar, Arti; Kachroo, Preeti; Herve, Maxime; Petruschke, Richard.
Afiliação
  • Dhar A; Consumer Healthcare R&D, Haleon (formerly GSK Consumer Healthcare), Singapore.
  • Kachroo P; Consumer Healthcare R&D, Haleon (formerly GSK Consumer Healthcare), Singapore.
  • Herve M; Consumer Healthcare R&D, Haleon (formerly GSK Consumer Healthcare), Singapore.
  • Petruschke R; US Medical Affairs, Haleon (formerly GSK Consumer Healthcare), Warren, NJ 07059, USA.
Pain Manag ; 13(1): 61-69, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36515014
COVID-19 is an infection caused by SARS-CoV-2. The COVID-19 pandemic not only affects patient lives, but also heavily impacts healthcare systems. This review aims to discuss the available literature on how to manage pain from COVID-19 and encourage a consensus meeting for recommendations. As most patients with COVID-19 are being managed in the outpatient setting, lifestyle interventions and over the counter analgesics are readily available options to effectively treat pain and fever, which can help to decrease the demand on the healthcare system during the COVID-19 pandemic.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article